Search Results - "van Ormondt, H"

Refine Results
  1. 1

    Specific tumor-cell killing with adenovirus vectors containing the apoptin gene by Pietersen, A M, van der Eb, M M, Rademaker, H J, van den Wollenberg, D J, Rabelink, M J, Kuppen, P J, van Dierendonck, J H, van Ormondt, H, Masman, D, van de Velde, C J, van der Eb, A J, Hoeben, R C, Noteborn, M H

    Published in Gene therapy (01-05-1999)
    “…Specificity is an essential prerequisite for cancer gene therapy. Recently we described that apoptin, a protein of 121 amino acids which is derived from the…”
    Get full text
    Journal Article
  2. 2

    Photodynamic treatment of adenoviral vectors with visible light: an easy and convenient method for viral inactivation by Schagen, F H, Moor, A C, Cheong, S C, Cramer, S J, van Ormondt, H, van der Eb, A J, Dubbelman, T M, Hoeben, R C

    Published in Gene therapy (01-05-1999)
    “…Recombinant adenovirus vectors are popular tools for gene transfer and gene therapy. However biosafety constraints require that all handling of the vectors and…”
    Get full text
    Journal Article
  3. 3

    Ammonium sulphate precipitation of recombinant adenovirus from culture medium : an easy method to increase the total virus yield by SCHAGEN, F. H. E, RADEMAKER, H. J, RABELINK, M. J. W. E, VAN ORMONDT, H, FALLAUX, F. J, VAN DER EB, A. J, HOEBEN, R. C

    Published in Gene therapy (01-09-2000)
    “…In the majority of the methods for purifying and concentrating recombinant adenoviruses (rAds) the virus that is associated with the helper cells is harvested,…”
    Get full text
    Journal Article
  4. 4

    Towards integrating vectors for gene therapy: expression of functional bacteriophage MuA and MuB proteins in mammalian cells by Schagen, F H, Rademaker, H J, Cramer, S J, van Ormondt, H, van der Eb, A J, van de Putte, P, Hoeben, R C

    Published in Nucleic acids research (01-12-2000)
    “…Bacteriophage Mu has one of the best studied, most efficient and largest transposition machineries of the prokaryotic world. To harness this attractive…”
    Get full text
    Journal Article
  5. 5

    The primary structure of elongation factor EF‐1 alpha from the brine shrimp Artemia by Hemert, F.J., Amons, R., Pluijms, W.J., Ormondt, H., Möller, W.

    Published in The EMBO journal (01-05-1984)
    “…cDNA as well as amino acid sequencing has revealed the complete primary structure of elongation factor EF‐1 alpha from the brine shrimp Artemia. A comparison…”
    Get full text
    Journal Article
  6. 6

    Inactivation of the Moloney murine leukemia virus long terminal repeat in murine fibroblast cell lines is associated with methylation and dependent on its chromosomal position by HOEBEN, R. C, MIGCHIELSEN, A. A. J, VAN DER JAGT, R. C. M, VAN ORMONDT, H, VAN DER EB, A. J

    Published in Journal of Virology (01-02-1991)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  7. 7

    Naturally occurring BK virus variants (JL and Dik) with deletions in the putative early enhancer-promoter sequences by TER SCHEGGET, J, SOL, C. J. A, WOUTERS BAAN, E, VAN DER NOORDAA, J, VAN ORMONDT, H

    Published in Journal of Virology (01-01-1985)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  8. 8

    Chicken anemia virus strains with a mutated enhancer/promoter region share reduced virus spread and cytopathogenicity by Noteborn, Mathieu H.M., Verschueren, Claudia A.J., van Ormondt, Hans, van der Eb, Alex J.

    Published in Gene (26-11-1998)
    “…Plasmid pCAV/E contains an infectious cloned double-stranded CAV (chicken anemia virus) DNA genome (Noteborn et al., J. Virol. 65 (1991) 3131–3139). We have…”
    Get full text
    Journal Article
  9. 9

    Toward gene therapy in haemophilia A: retrovirus-mediated transfer of a factor VIII gene into murine haematopoietic progenitor cells by Hoeben, R C, Einerhand, M P, Briët, E, van Ormondt, H, Valerio, D, van der Eb, A J

    Published in Thrombosis and haemostasis (02-03-1992)
    “…To study and evaluate the potential of the haematopoietic system as a target for gene therapy in haemophilia A, we have infected murine bone-marrow cells with…”
    Get more information
    Journal Article
  10. 10

    Adenosine deaminase: characterization and expression of a gene with a remarkable promoter by Valerio, D., Duyvesteyn, M.G., Dekker, B.M., Weeda, G., Berkvens, T.M., Voorn, L., Ormondt, H., Eb, A.J.

    Published in The EMBO journal (01-02-1985)
    “…Cosmid clones containing the gene for human adenosine deaminase (ADA) were isolated. The gene is 32 kb long and split into 12 exons. The exact sizes and…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Photodynamic inactivation of retroviruses by phthalocyanines: the effects of sulphonation, metal ligand and fluoride by Ben-Hur, E, Hoeben, R C, Van Ormondt, H, Dubbelman, T M, Van Steveninck, J

    “…The photodynamic inactivation of retroviruses was investigated using aluminium and zinc phthalocyanine (Pc) derivatives. The N2 retrovirus packaged in either…”
    Get more information
    Journal Article
  13. 13

    Expression of functional factor VIII in primary human skin fibroblasts after retrovirus-mediated gene transfer by HOEBEN, R. C, VAN DER JAGT, R. M. C, SCHOUTE, F, VAN TIBURG, N. H, VERBEET, M. P, BRIET, E, VAN ORMONDT, H, VAN DER EB, A. J

    Published in The Journal of biological chemistry (05-05-1990)
    “…We have developed a retroviral-vector system for the transfer and expression of a cloned blood clotting factor VIII cDNA. Since inclusion of the complete cDNA…”
    Get full text
    Journal Article
  14. 14
  15. 15

    New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses by Fallaux, F J, Bout, A, van der Velde, I, van den Wollenberg, D J, Hehir, K M, Keegan, J, Auger, C, Cramer, S J, van Ormondt, H, van der Eb, A J, Valerio, D, Hoeben, R C

    Published in Human gene therapy (01-09-1998)
    “…The presence of replication-competent adenoviruses (RCAs) in batches of replication-defective adenovirus (Ad) vectors is a major problem for the application of…”
    Get more information
    Journal Article
  16. 16

    Comparison of nucleotide sequences of the early E1a regions for subgroups A, B and C of human adenoviruses by van Ormondt, H, Maat, J, Dijkema, R

    Published in Gene (01-12-1980)
    “…The early E1a regions (map position (0--4.5%) of highly oncogenic (subgroup A) adenovirus serotype 12 (Ad12), weakly oncogenic (subgroup B) adenovirus serotype…”
    Get more information
    Journal Article
  17. 17

    Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors by Fallaux, F J, Kranenburg, O, Cramer, S J, Houweling, A, Van Ormondt, H, Hoeben, R C, Van Der Eb, A J

    Published in Human gene therapy (20-01-1996)
    “…Currently, the preferred host for the production of early region-1 (E1)-deleted recombinant adenoviruses (rAdV) is cell line 293, which was generated by…”
    Get more information
    Journal Article
  18. 18

    The nucleotide sequence of the transforming HindIII-G fragment of adenovirus type 5 DNA. The region between map positions 4.5 (HpaI site) and 8.0 (HindIII site) by Maat, J, Van Ormondt, H

    Published in Gene (01-01-1979)
    “…The nucleotide sequence of the region between map positions 4.5 (HpaI-site) and 8.0 (HindIII-site) of adenovirus type 5 (Ad5) DNA has been determined. This…”
    Get more information
    Journal Article
  19. 19

    The nucleotide sequence of the transforming HpaI-E fragment of adenovirus type 5 DNA by Van Ormondt, H, Maat, J, De Waard, A, Van der Eb, A J

    Published in Gene (01-12-1978)
    “…The primary structure of the HpaI-E fragment of adenovirus type 5 (Ad5) DNA has been determined, mainly by the method of Maxam and Gilbert (1977). This…”
    Get more information
    Journal Article
  20. 20

    One adenosine deaminase allele in a patient with severe combined immunodeficiency contains a point mutation abolishing enzyme activity by Valerio, D., Dekker, B.M., Duyvesteyn, M.G., Voorn, L., Berkvens, T.M., Ormondt, H., Eb, A.J.

    Published in The EMBO journal (01-01-1986)
    “…We have cloned and sequenced an adenosine deaminase (ADA) gene from a patient with severe combined immunodeficiency (SCID) caused by inherited ADA deficiency…”
    Get full text
    Journal Article